Loading...
XNAS
ISRG
Market cap181bUSD
Apr 02, Last price  
507.05USD
1D
2.15%
1Q
-3.24%
Jan 2017
619.63%
Name

Intuitive Surgical Inc

Chart & Performance

D1W1MN
P/E
78.22
P/S
21.75
EPS
6.48
Div Yield, %
Shrs. gr., 5y
0.19%
Rev. gr., 5y
13.27%
Revenues
8.35b
+17.24%
227,338,000372,682,000600,828,000874,919,0001,052,168,0001,413,000,0001,757,300,0002,178,800,0002,265,100,0002,131,700,0002,384,400,0002,704,400,0003,128,900,0003,724,200,0004,478,500,0004,358,400,0005,710,100,0006,222,200,0007,124,100,0008,352,100,000
Net income
2.32b
+29.18%
94,134,00072,044,000144,537,000204,315,000232,606,000381,800,000495,100,000656,600,000671,000,000418,800,000588,800,000735,900,000660,000,0001,127,900,0001,379,300,0001,060,600,0001,704,600,0001,322,300,0001,798,000,0002,322,600,000
CFO
2.42b
+33.15%
70,787,00099,845,000205,687,000278,235,000385,055,000528,000,000677,600,000814,200,000880,000,000665,100,000771,900,0001,042,900,0001,143,900,0001,169,600,0001,598,200,0001,484,800,0002,089,400,0001,490,800,0001,813,800,0002,415,000,000
Earnings
Apr 16, 2025

Profile

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
IPO date
Jun 13, 2000
Employees
12,120
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
8,352,100
17.24%
7,124,100
14.49%
6,222,200
8.97%
Cost of revenue
3,863,200
3,393,400
2,905,200
Unusual Expense (Income)
NOPBT
4,488,900
3,730,700
3,317,000
NOPBT Margin
53.75%
52.37%
53.31%
Operating Taxes
336,300
141,600
262,400
Tax Rate
7.49%
3.80%
7.91%
NOPAT
4,152,600
3,589,100
3,054,600
Net income
2,322,600
29.18%
1,798,000
35.98%
1,322,300
-22.43%
Dividends
Dividend yield
Proceeds from repurchase of equity
(120,000)
(2,373,600)
BB yield
0.10%
2.47%
Debt
Debt current
24,200
Long-term debt
129,000
139,200
Deferred revenue
45,600
41,000
Other long-term liabilities
468,300
275,400
398,300
Net debt
(8,832,400)
(7,214,200)
(9,201,700)
Cash flow
Cash from operating activities
2,415,000
1,813,800
1,490,800
CAPEX
(1,111,200)
(1,064,200)
(532,400)
Cash from investing activities
(3,272,800)
(360,100)
1,370,800
Cash from financing activities
150,900
(287,600)
(2,572,300)
FCF
2,654,300
1,470,600
2,452,200
Balance
Cash
4,013,300
5,223,200
6,741,500
Long term investments
4,819,100
2,120,000
2,623,600
Excess cash
8,414,795
6,986,995
9,053,990
Stockholders' equity
6,848,300
4,820,900
3,408,700
Invested Capital
10,149,600
8,961,900
7,701,600
ROIC
43.46%
43.08%
41.19%
ROCE
26.41%
27.07%
30.04%
EV
Common stock shares outstanding
362,000
357,400
362,000
Price
521.96
54.72%
337.36
27.14%
265.35
-26.15%
Market cap
188,949,520
56.71%
120,572,464
25.52%
96,056,700
-26.92%
EV
180,213,020
113,447,964
86,925,700
EBITDA
4,950,900
4,152,500
3,682,800
EV/EBITDA
36.40
27.32
23.60
Interest
29,700
Interest/NOPBT
0.90%